Aquit Nets $832K in Pre-Seed Funding to Transform Aquaculture with Innovative Fish Immunity Technology

Aquit is excited to announce a pivotal funding milestone, having raised $832,000 to support its groundbreaking work in aquaculture biotechnology. This significant investment underscores the growing confidence of our investors in Aquit’s vision of transforming fish farming practices for a more sustainable and efficient future. As a biotech company at the forefront of innovation, Aquit is dedicated to developing disruptive, cost-effective technology that enhances fish immunity, improves survival rates, and provides a viable alternative to antibiotics. The funds will be strategically directed toward advancing our research and development efforts, propelling our technology from successful laboratory prototypes to fully scalable, field-ready solutions that address real-world challenges in aquaculture. This round of funding not only validates the robustness of our scientific approach but also fuels our commitment to deliver effective, environmentally responsible solutions that promote healthier aquatic ecosystems. By reducing reliance on antibiotics, Aquit is set to revolutionize the industry, contributing to safer, more sustainable aquaculture practices that benefit both producers and consumers. The injection of $832,000 marks a transformative stage in our journey, enabling us to accelerate our product development, expand our research team, and initiate new pilot projects with industry partners. As we move forward, we remain dedicated to our mission of delivering innovative solutions that enhance fish health and sustainability, while ensuring that aquaculture continues to thrive as a critical source of nutrition globally. With this new funding, Aquit is well-positioned to lead the wave of change in the aquaculture industry, paving the way for a future where science and sustainability go hand in hand.